References
- Charnock-Jones DS, Burton GJ. Placental vascular morphogenesis. Best Pract Res Clin Obstet Gynaecol. 2000;14(6):953–968.
- Zhang J, Mikolajczyk R, Grewal J, et al. Prenatal application of the individualized fetal growth reference. Am J Epidemiol. 2011;173(5):539–543.
- Bosco C, González J, Gutiérrez R, et al. Oxidative damage to preeclamptic placenta: immunohistochemically expression of VEGF, nitrotyrosine residues and von Willebrand factor. J Matern Fetal Neonatal Med. 2012;25(11):2339–2345.
- Pritchard K, Moody CJ. Caldesmon: a calmodulin-binding actin-regulatory protein. Cell Calcium. 1986;7(5–6):309–327.
- Gusev NB. Some properties of caldesmon and calponin and the participation of these proteins in regulation of smooth muscle contraction and cytoskeleton formation. Biochemistry (Mosc). 2001;66(10):1112–1121.
- Gusev NB, Vorotnikov AV, Biriukov KG, et al. Caldesmon and calponin are proteins, participating in the regulation of myosin and actin interaction in nonmuscle and smooth muscle cells. Biochemistry. 1991;56(8):1347–1368.
- Bilodeau JF. Review: maternal and placental antioxidant response to preeclampsia – impact on vasoactive eicosanoids. Placenta. 2014;28:S32–S38.
- Fujimaki A, Watanabe K, Mori T, et al. Placental oxidative DNA damage and its repair in preeclamptic women with fetal growth restriction. Placenta. 2011;32(5):367–372.
- Yung HW, Atkinson D, Campion-Smith T, et al. Differential activation of placental unfolded protein response pathways implies heterogeneity in causation of early- and late-onset pre-eclampsia. J Pathol. 2014;234(2):262–276.
- Ozaydın T, Sur E, Oznurlu Y, et al. Immunohistochemical distribution of heat shock protein 70 and proliferating cell nuclear antigen in mouse placenta at different gestational stages. Microcc Res Tech. 2016;79(4):251–257.
- Hnat MD, Meadows JW, Brockman DE, et al. Heat shock protein-70 and 4-hydroxy-2-nonenal adducts in human placental villous tissue of normotensive, preeclamptic and intrauterine growth restricted pregnancies. Am J Obstet Gynecol. 2005;193(3 Pt 1):836–840.
- Mistry HD, Wilson V, Ramsay MM, et al. Reduced selenium concentrations and glutathione peroxidase activity in preeclamptic pregnancies. Hypertension. 2008;52(5):881–888.
- Chekir C, Nakatsuka M, Noguchi S, et al. Accumulation of advanced glycation end products in women with preeclampsia: possible involvement of placental oxidative and nitrative stress. Placenta. 2006;27(2–3):225–233.
- Hromadnikova I, Dvorakova L, Kotlabova K, et al. Assessment of placental and maternal stress responses in patients with pregnancy related complications via monitoring of heat shock protein mRNA levels. Mol Biol Rep. 2015;42(3):625–637.
- Sheikhi A, Razdar S, Rahmanpour H, et al. Higher expression of HSP70 and LOX-1 in the placental tissues of pre-eclampsia pregnancies. Clin Exp Hypertens. 2015;37(2):128–135.
- Abdulsid A, Hanretty K, Lyall F. Heat shock protein 70 expression is spatially distributed in human placenta and selectively upregulated during labor and preeclampsia. PLoS One. 2013;8(1):e54540.
- Parra-Cordero M, Bosco C, González J, et al. Immunohistochemical expression of von Willebrand factor in the preeclamptic placenta. J Mol Histol. 2011;42(5):459–465.
- Escudero C, Celis C, Saez T, et al. Increased placental angiogenesis in late and early onset pre-eclampsia is associated with differential activation of vascular endothelial growth factor receptor 2. Placenta. 2014;35(3):207–215.
- Leik CE, Willey A, Graham MF, et al. Isolation and culture of arterial smooth muscle cells from human placenta. Hypertension. 2004;43(4):837–840.